Berlin - Delayed Quote EUR

Aurinia Pharmaceuticals Inc (IKAP.BE)

Compare
8.59 -0.03 (-0.32%)
At close: December 23 at 8:13:02 AM GMT+1
Loading Chart for IKAP.BE
DELL
  • Previous Close 8.62
  • Open 0.00
  • Bid 8.50 x --
  • Ask 8.85 x --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 9.81
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 13, 2025 - Feb 17, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: IKAP.BE

View More

Performance Overview: IKAP.BE

Trailing total returns as of 12/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IKAP.BE
6.76%
S&P 500
26.63%

1-Year Return

IKAP.BE
3.67%
S&P 500
27.03%

3-Year Return

IKAP.BE
25.04%
S&P 500
27.81%

5-Year Return

IKAP.BE
51.17%
S&P 500
87.35%

Compare To: IKAP.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IKAP.BE

View More

Valuation Measures

Annual
As of 12/23/2024
  • Market Cap

    1.23B

  • Enterprise Value

    978.48M

  • Trailing P/E

    --

  • Forward P/E

    13.23

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.89

  • Price/Book (mrq)

    3.31

  • Enterprise Value/Revenue

    4.63

  • Enterprise Value/EBITDA

    232.47

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: IKAP.BE

View More

Company Insights: IKAP.BE

Research Reports: IKAP.BE

View More